Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine.
Allergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two pivotal phase 3 clinical...
Global Women’s Health Divestiture to CVC Capital Partners completed declares Teva
Teva Pharmaceutical Industries Ltd. announced it has completed the sale of a portfolio of products within its global women’s health business across contraception, fertility,...
Guidelines extended to improve the use of feedback from patients in clinical trials.
Researchers recommend changes to international guidelines used in the development of clinical trials in an effort to obtain useful information about the impact of...
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
MacroGenics, Inc. a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced presentation of data...
Vantage Cancer Care Network Collaborates with Alliance Cancer Specialists, PC, to Expand the Delivery of High-Quality Cancer Care across Philadelphia
Vantage Cancer Care Network (VCCN), a leader in value-based integrated cancer care, announced an agreement with Alliance Cancer Specialists, PC, to expand the delivery...
START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer
South Texas Research Accelerated Therapeutics (START) and Sarah Cannon Research Institute announced a new collaboration to complement and enhance their globally recognized phase I...
BioProtect begins study of ProSpace biodegradable spacer to protect rectum, lower GI tract during radiation therapy
BioProtect, the technology leader in biodegradable balloon spacers protecting normal tissue during radiation therapy, announced the launch of its clinical trial following Investigational Device...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...